Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis

Saved in:
Bibliographic Details
Published in:Neurology and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301678868332547
collection WordPress RSS
FRELIP Feed Integration
container_title Neurology and Therapy
description
discipline_display Psychiatry and Neurology
discipline_facet Psychiatry and Neurology
format Online Article
RSS Article
genre Journal Article
id rss_article:59295
institution FRELIP
journal_source_facet Neurology and Therapy
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis
Psychiatry and Neurology
General
Psychiatry and Neurology
sub_discipline_display General
sub_discipline_facet General
subject_display Psychiatry and Neurology
General
Psychiatry and Neurology
Psychiatry and Neurology
General
Psychiatry and Neurology
subject_facet Psychiatry and Neurology
General
Psychiatry and Neurology
title Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis
title_auth Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis
title_full Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis
title_fullStr Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis
title_full_unstemmed Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis
title_short Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis
title_sort real-world treatment switch rates, and healthcare costs of botulinum toxin type a among patients with cervical dystonia in the usa: a retrospective claims analysis
topic Psychiatry and Neurology
General
Psychiatry and Neurology
url https://link.springer.com/article/10.1007/s40120-026-00967-3